Table 2.
Gene | Effect | Variant | Gene | Effect | Variant | ||
---|---|---|---|---|---|---|---|
CFH | Complete FH deficiency (homozygous) | P88T* | [66, 74] | CFH | VUS (normal FH levels) | P26S | £ |
R127L* | [73] | ΔG122-E128 | [65] | ||||
C431S | [65, 73] | D130N | [65] | ||||
C597R | [65] | A161S | [65] | ||||
P621Y | [75] | IVS11 + 5 | [65] | ||||
C673S | [73] | G334A | £ | ||||
Y899X | [76] | G650V | [64], £ | ||||
Y1008X | [66] | F717L | [65] | ||||
W1096R* | £ | H878Y | 2 | ||||
Partial FH deficiency | P76X | [64] | A892V | 3 | |||
L77X | [65] | R1210V | [65] | ||||
V143I | [65] | VUS (FH levels not known) | R127C | [66] | |||
I216T | [77] | S199G/E1172X | £ | ||||
R232X | [65], £ | C431S | £ | ||||
C673R | [65] | N516K | [78] | ||||
K768X | [76] | V609I | £ | ||||
C1043X | [65] | M725X | [79] | ||||
Functional FH deficiency (homozygous) | R78G | [66] | V837I/E1145D | [78] | |||
ΔK224* | [80] | Q950H | [66] | ||||
R53C | [65, 81] | T956M | [78] [82] [66] | ||||
Functional FH deficiency | R83S* | [83] | C3 | Gain of function | Δ923-924DG* | [84] | |
R1210C | [64] [66] | I756T* | [85] | ||||
R53C | [65] [86] | R161W | [87] | ||||
CD46 | VUS | K66N | [66, 88] | VUS | R148Q | [87] | |
V181M | [65] | A443S | [87] | ||||
CFI | FI deficiency | G119R | [65, 89–91] | L1100P | [87] | ||
A240G | [65, 92, 93] | L1318R | [87] | ||||
C309R | [65] | V86I | [66] | ||||
C327R | [65] | R505C | [66] | ||||
VUS | c.1-4C > T | [66] | V619M | [66] | |||
G57D | [66] | G637R | [66] | ||||
None | G261D | [65, 79, 91, 94] | R1042Q | [66] | |||
I306S | [65] | S1063N | [66] | ||||
CFB | Gain of function | I242L | [87] | R1303H | [66] | ||
VUS | D279E | [87] | R1320Q | [66] | |||
S367R* | [95] | D1362N | [66] | ||||
G161R | [66] | C1518R | [66] | ||||
H451R | [66] | D1625H | [66] | ||||
R679W | [66] | None | K1051M | [66] |
All variants heterozygous except where indicated
VUS variant of uncertain significance, FH complement factor H, FI complement factor I. * reported in familial disease, £ unpublished, Δ amino acid deletion